about
Metabolomic Elucidation of the Effects of Curcumin on Fibroblast-Like Synoviocytes in Rheumatoid ArthritisKuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.Combination of lipid metabolism alterations and their sensitivity to inflammatory cytokines in human lipin-1-deficient myoblastsThe association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS)Low levels of CD36 in peripheral blood monocytes in subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study in a Mexican population.Combined elevated midpregnancy tumor necrosis factor alpha and hyperlipidemia in pregnancies resulting in early preterm birth.Energy expenditure in Japanese patients with severe or moderate ulcerative colitisLipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation.The effects of erythropoietin dose titration during high-fat diet-induced obesity.Trichostatin A modulates thiazolidinedione-mediated suppression of tumor necrosis factor α-induced lipolysis in 3T3-L1 adipocytesTetradecylthioacetic acid increases hepatic mitochondrial β-oxidation and alters fatty acid composition in a mouse model of chronic inflammationRelative contribution of adipose triglyceride lipase and hormone-sensitive lipase to tumor necrosis factor-α (TNF-α)-induced lipolysis in adipocytes.Comparison of energy metabolism and nutritional status of hospitalized patients with Crohn's disease and those with ulcerative colitis.Impact of 3-Amino-1,2,4-Triazole (3-AT)-Derived Increase in Hydrogen Peroxide Levels on Inflammation and Metabolism in Human Differentiated AdipocytesAssociation of a polymorphism of BTN2A1 with dyslipidemia in East Asian populations.Tributyltin and dibutyltin alter secretion of tumor necrosis factor alpha from human natural killer cells and a mixture of T cells and natural killer cellsBeneficial effects of flaxseed oil and fish oil diet are through modulation of different hepatic genes involved in lipid metabolism in streptozotocin-nicotinamide induced diabetic rats.Insulin signalling mechanisms for triacylglycerol storage.The G0/G1 switch gene 2 (G0S2): regulating metabolism and beyond.The relationship between dietary fatty acids and inflammatory genes on the obese phenotype and serum lipids.Beyond the joints in rheumatoid arthritis: Effects of adalimumab on hematologic and lipid indicesWhole-body cryostimulation as an effective method of reducing low-grade inflammation in obese men.TNF-α induces vascular insulin resistance via positive modulation of PTEN and decreased Akt/eNOS/NO signaling in high fat diet-fed mice.Effects of anti-TNF-α treatment on lipid profile in rheumatic diseases: an analytical cohort study.Keeping It All Going-Complement Meets MetabolismAcute rhabdomyolysis and inflammation.Effects of celecoxib and ibuprofen on metabolic disorders induced by Walker-256 tumor in rats.The impact of maternal obesity on inflammatory processes and consequences for later offspring health outcomes.G0S2: A small giant controller of lipolysis and adipose-liver fatty acid flux.Polymorphisms of the TNF-α gene interact with plasma fatty acids on inflammatory biomarker profile: a population-based, cross-sectional study in São Paulo, Brazil.Inflammatory biomarkers and spontaneous preterm birth among obese women.Functional Comparison for Lipid Metabolism and Intestinal and Fecal Microflora Enzyme Activities between Low Molecular Weight Chitosan and Chitosan Oligosaccharide in High-Fat-Diet-Fed Rats.Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosis.Intestinal inflammation requires FOXO3 and prostaglandin E2-dependent lipogenesis and elevated lipid droplets.Adipose tissue and metabolic and inflammatory responses to stroke are altered in obese mice.Exercise-induced brachial artery blood flow and vascular function is impaired in systemic sclerosis.Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.Evaluation of serum interleukin 6 and tumour necrosis factor alpha levels, and their association with various non-immunological parameters in renal transplant recipients.Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model.Erythrodermic psoriasis peculiarly sparing anti-TNF injection sites in a patient with secondary loss of efficacy.
P2860
Q28603409-5F850B97-D18A-4CB4-8FE3-B27A1D9AF9C6Q30416248-2105AE05-42DE-457D-A369-98BCD622CA6DQ33554610-F1457869-5593-44C2-869F-393D14E4543AQ33567573-50E66AF1-07A6-4F5D-903B-2C5A9C1D0CE8Q33805096-D0582FAC-997F-46BC-873E-38A7E379D6EBQ33983363-A18E4F0E-BF88-4E3E-8DE8-ECCC12B60099Q33983549-1BB25EF1-7B14-4A7C-8CF3-4DB9267E22F7Q34154684-BAA6745B-DBF8-467B-B6EE-6D6D3BEFABC2Q34897067-39F8932F-52C4-4C08-ACD1-A2B716A50177Q34949771-5481A378-1C14-4709-B409-B74EE1F5635EQ35091569-3E89C774-8615-48D7-88DE-F4F997FD288FQ35562565-DA757944-09D5-458A-8144-04031514760FQ35678990-0C3B91F8-E125-4028-A7FE-02E20C6AD8E5Q35972943-254866B1-CF5C-4F40-AFCA-2FE401C77402Q36230703-87364498-BC38-497D-9913-21B06291EDF5Q36605357-9F7A2B49-99D8-474A-8FB8-EC1060854DC0Q36803841-362F5B10-16B5-4F58-8BA5-9A65BD83D2D3Q36838847-7F45EE19-8BBD-408D-BBA2-50FB3991219CQ36972427-8D4AAE78-46CB-4CB4-9BDA-6D4B6F65139AQ37002572-0D72B4AC-DE01-4E97-83B9-542B128E4B87Q37064901-AAB5E118-E252-43DD-A3F0-7188124A3F44Q37115527-86D5873D-5F0C-4016-99F4-B0A932E85616Q37209584-B540B77D-D16D-4CA8-973D-EC323184A1A5Q37405950-70C9302C-F1F2-4A0C-94EC-2D7C9D52F336Q37590579-FEE4C810-FCE6-43CD-B342-39BE9BA77BE8Q38380755-AA3491D7-5C87-414E-8002-EC8EF7361AC8Q38943695-A969376E-962D-4BFC-8380-D345FD36A0C0Q39200967-DE813020-C5A2-47E7-87FF-D4D9A0BC7225Q39395189-2C312DED-3E43-40D2-80AC-CE33DE268FFFQ40152405-8130357E-9B0D-4E82-81C3-F180F9983EDEQ41024413-02318E66-C7A7-4F50-B1D4-566D18ADE597Q41162080-A7A8EB3F-239C-4E7C-91D8-1F08D48CD0D1Q42379517-E49E43F9-C2B8-44F4-BF1A-AE2C1A797609Q42739026-85C794D0-A530-497E-84FE-7D2EFC1AEE2AQ42972901-768FC2C1-D1D2-4D26-8802-678E7CB91957Q45044093-2FFD693D-C86A-48CD-B712-33A8E7A8BD6EQ45077865-7CBD1377-0153-4F11-8B47-F2AFD8CD762AQ46171681-38B6BB99-ABE5-455B-A0CA-3AABF73A50C9Q47195879-E22CE88B-A1BB-4977-AB13-E891FB36BB48Q48246214-99895BB0-CAF8-403A-9C4D-97E6D151CF46
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TNF-alpha, a potent lipid metabolism regulator.
@en
TNF-alpha, a potent lipid metabolism regulator.
@nl
type
label
TNF-alpha, a potent lipid metabolism regulator.
@en
TNF-alpha, a potent lipid metabolism regulator.
@nl
prefLabel
TNF-alpha, a potent lipid metabolism regulator.
@en
TNF-alpha, a potent lipid metabolism regulator.
@nl
P2093
P2860
P356
P1476
TNF-alpha, a potent lipid metabolism regulator.
@en
P2093
Lidian Chen
Xiuping Chen
Yitao Wang
P2860
P304
P356
10.1002/CBF.1596
P577
2009-10-01T00:00:00Z